TMCnet News
Seeking To Evaluate Commercial Products, or Products in Development, for In Vitro Serological Diagnosis of PertussisDec 15, 2008 (Centers for Disease Control and Prevention Documents and Publications/ContentWorks via COMTEX) -- SUMMARY: The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD), Division of Bacterial Diseases (DBD) through its component Branches have lead technical responsibility for research, development and evaluation of diagnostic tools for pertussis and application of these to epidemiologic studies of pertussis. CDC uses epidemiologic, laboratory, clinical, and biostatistical sciences to control and prevent vaccine preventable infectious diseases. CDC also conducts applied research in a variety of settings, and translates the findings of this research into public health practice. FOR FURTHER INFORMATION CONTACT: Dr. M. Lucia Tondella, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), 1600 Clifton Road NE., Mail Stop D-11, Atlanta, GA 30333. Telephone (404) 639-1239, E-Mail at [email protected]. Business Lisa Blake-DiSpigna, Technology Development Coordinator, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), 1600 Clifton Road NE., Mail Stop A-42, Atlanta, GA 30333. Telephone (404) 639-2620, E-Mail at [email protected]. Dated: December 3, 2008. James D. Seligman, Chief Information Officer, Centers for Disease Control and Prevention. Notice. Citation: "73 FR 76031" Federal Register Page Number: "76031" "Notices" |